Bioscal® Scientific Research
1. More than 25 years of research
- Conducted by Professor Kai Setälä, MD, and Dr. Ilona Schreck-Purola, MD, University of Helsinki, Finland
- Additional clinical studies by numerous medical doctors and clinical researchers in several countries
2. Over 1,000 compounds tested - only 1 had superior effects on hair growth
Certain non-ionic surface-active agents cause a shift in the hair follicular cycle into the anagen (growth phase) and thus an enhancement of the hair growth.
3. Documented mode of action
The beneficial effect of Bioscal® on hair growth is caused by its ability to:- Dissolve cholesterol and DHT (DiHydroTestosterone) in the cell wall of the hair follicles
- Change the relative proportions of naturally occurring steroids and steroid metabolites in the follicles
- Promote cell division and a shift from resting phase to growth (anagen) phase
- Stimulate growth of the hair follicle
- Amino acids, which are important components of keratin, the basic building material of the hair;
- Vitamins that are essential for healthy hair growth; and
- Compounds that improve the peripheral blood flood and thus the supply of nutrients and oxygen to the hair follicles.
4. First clinical trial (Finland)
- 320 volunteers, aged between 20 and 65 years
- 9 months average observation (representing 125 treatment-years)
- Complete inhibition of excessive hair loss
- Thicker and stronger hair strands
- Distinct regeneration of hair growth in bald scalp areas occurred in more than 60% of the subjects
- Eradication of scale formation on the scalp (dandruff)
- No skin irritation, no allergies, no side effects
5. Collaborative dermatology study (France)
- 70 dermatologists (MDs)
- 451 healthy male subjects with male pattern alopecia and stage 1 to 5 baldness, average age of 33 years
- 30 weeks treatment and observation of each individual test subject (representing 260 treatment-years)
- According to the doctors, 94% had significantly improved hair growth, 89% according to the test subjects themselves
- 99% did not experience any adverse effect
6. Androgen-genetic hair loss study (France)
- 46 adult male subjects with androgen-genetic hair loss and stage 1 to 7 baldness
- 10 months treatment and observations period
- Clinically observed results obtained using trichogram
- A significant increase in anagenes (hair follicles in growth phase) and a reduction in telogenes (hair follicles in resting phase) in all areas: crown, templates and back of head
- A progressive decrease in the number of persons suffering from loss of hair from the second month onwards, coupled with considerable increase in hair growth from the sixth month onwards
- A significant effect on the new growth of hair in 66% of the subjects
- No signs of incompatibility; all test persons were able to carry out the treatment to its conclusion
7. Histoquantitative clinical study (Finland)
- 167 test subjects between 18 and 43 years of age
- 505 scalp biopsies taken from bald areas, border areas and areas with hair growth
- 9 months treatment and observations period
- The number of active hair follicles within the balding and bald areas increased in 85% of the subjects
8. Market research (Canada)
- Conducted by York Enterprise Development Centre of York University in Toronto
- Detailed questionnaire mailed to 1,500 Bioscal users
- 70% stated that they were pleased with the performance of the treatment
9. Before and after photos (Canada)
Subject 1 | Subject 2 | ||
---|---|---|---|
Before treatment | After 9 months | Before treatment | After 9 months |
10. Bioscal® and the hair exchange cycle
|
|
|
|
|
|
11. Conclusions
- Bioscal® works
- Bioscal® is safe and well tolerated
- Bioscal® is cosmetically attractive